← Back to Search

Youth-Focused Economic Empowerment Approach

Economic Empowerment for HIV Treatment Adherence

Masaka, Uganda
N/A
Waitlist Available
Led By Fred M Ssewamala, MSW, PhD
Research Sponsored by Washington University School of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Prescribed antiretroviral therapy
10-16 years of age at the time of enrollment
Must not have
Not HIV-positive
HIV-positive but not prescribed antiretroviral therapy
Timeline
Screening 3 weeks
Treatment Varies
Follow Up every year in years 6 to 10
Awards & highlights
No Placebo-Only Group

Summary

This trial is examining whether an innovative intervention that includes an economic empowerment component can increase adherence to HIV treatment among adolescents in Uganda.

See full description
Who is the study for?
This trial is for HIV-positive adolescents aged 10-16 in southern Uganda, who are on antiretroviral therapy and enrolled at one of the specified 40 medical clinics. They must be living within a family setting, but not necessarily with biological parents.Check my eligibility
What is being tested?
The study tests Suubi+Adherence, an economic empowerment intervention aimed to improve HIV treatment adherence among youth. It includes savings-led income generation to promote stability and applies it to their HIV treatment regimen.See study design
What are the potential side effects?
Since this trial focuses on economic empowerment rather than medication, traditional side effects related to drugs aren't applicable. However, there may be social or psychological impacts due to changes in financial status or responsibilities.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am on antiretroviral therapy.
 show original
Select...
I am between 10 and 16 years old.
 show original

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I do not have HIV.
 show original
Select...
I am HIV-positive and not on antiretroviral therapy.
 show original
Select...
I am between 10 and 16 years old.
 show original

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~every year in years 6 to 10
This trial's timeline: 3 weeks for screening, Varies for treatment, and every year in years 6 to 10 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change from baseline to follow-up assessments of adherence to HIV treatment
Secondary study objectives
Cognitive functioning
Cost-Effectiveness Analyses
HIV stigma
+3 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Suubi+AdherenceExperimental Treatment1 Intervention
Suubi+Adherence intervention arm provides: * Matched savings accounts/child development accounts (CDAs) for the adolescents held in a local bank. * Financial education and workshops on asset-building, future planning, and protection from risks * Mentorship from a young adult/near-peer * Family-based microenterprise development training Bolstered Standard of Care: Adherence Counseling Practices -Four to six counseling sessions to review HIV, ART, resistance, and adherence. Medical Standard of Care: -Pediatric ART initiation and monitoring followed by all public clinics, and outlined in National Department of Health Guidelines for pediatric HIV care in Uganda Psychosocial Standard of Care: -Psychosocial support provided by lay counselors trained in standardized ART adherence counseling
Group II: Bolstered Standard of CareActive Control1 Intervention
Bolstered Standard of Care: Adherence Counseling Practices -Four to six counseling sessions to review HIV, ART, resistance, and adherence. Medical Standard of Care: -Pediatric ART initiation and monitoring followed by all public clinics, and outlined in National Department of Health Guidelines for pediatric HIV care in Uganda Psychosocial Standard of Care: -Psychosocial support provided by lay counselors trained in standardized ART adherence counseling

Find a Location

Closest Location:Washington University in St. Louis· Saint Louis, MO· 332 miles

Who is running the clinical trial?

Washington University School of MedicineLead Sponsor
2,021 Previous Clinical Trials
2,349,191 Total Patients Enrolled
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH
2,098 Previous Clinical Trials
2,748,614 Total Patients Enrolled
Fred M Ssewamala, MSW, PhDPrincipal InvestigatorWashington University School of Medicine

Media Library

Suubi+Adherence (Youth-Focused Economic Empowerment Approach) Clinical Trial Eligibility Overview. Trial Name: NCT01790373 — N/A
HIV/AIDS Research Study Groups: Bolstered Standard of Care, Suubi+Adherence
HIV/AIDS Clinical Trial 2023: Suubi+Adherence Highlights & Side Effects. Trial Name: NCT01790373 — N/A
Suubi+Adherence (Youth-Focused Economic Empowerment Approach) 2023 Treatment Timeline for Medical Study. Trial Name: NCT01790373 — N/A
~25 spots leftby Aug 2025